- Home
- TXG vs CRI Comparison
TXG vs CRI Comparison
Compare TXG & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- CRI
- Stock Information
- Founded
- TXG 2012
- CRI 1865
- Country
- TXG United States
- CRI United States
- Employees
- TXG N/A
- CRI N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- CRI Apparel
- Sector
- TXG Industrials
- CRI Consumer Discretionary
- Exchange
- TXG Nasdaq
- CRI Nasdaq
- Market Cap
- TXG 1.0B
- CRI 1.3B
- IPO Year
- TXG 2019
- CRI 2003
- Fundamental
- Price
- TXG $8.63
- CRI $34.44
- Analyst Decision
- TXG Buy
- CRI Sell
- Analyst Count
- TXG 15
- CRI 5
- Target Price
- TXG $18.85
- CRI $36.20
- AVG Volume (30 Days)
- TXG 3.9M
- CRI 1.6M
- Earning Date
- TXG 05-08-2025
- CRI 04-25-2025
- Dividend Yield
- TXG N/A
- CRI 9.27%
- EPS Growth
- TXG N/A
- CRI N/A
- EPS
- TXG N/A
- CRI 4.51
- Revenue
- TXG $610,785,000.00
- CRI $2,812,437,000.00
- Revenue This Year
- TXG $0.71
- CRI N/A
- Revenue Next Year
- TXG $9.28
- CRI N/A
- P/E Ratio
- TXG N/A
- CRI $7.65
- Revenue Growth
- TXG N/A
- CRI N/A
- 52 Week Low
- TXG $6.78
- CRI $32.04
- 52 Week High
- TXG $28.25
- CRI $72.11
- Technical
- Relative Strength Index (RSI)
- TXG 51.19
- CRI 44.97
- Support Level
- TXG $7.72
- CRI $32.42
- Resistance Level
- TXG $8.63
- CRI $35.04
- Average True Range (ATR)
- TXG 0.43
- CRI 1.60
- MACD
- TXG 0.14
- CRI 0.12
- Stochastic Oscillator
- TXG 84.92
- CRI 33.57
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About CRI Carter's Inc.
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.